Local production of TGF β1 inhibits cerebral edema, enhances TNF-α induced apoptosis and improves survival in a murine glioma model

被引:24
作者
Ashley, DM
Sampson, JH
Archer, GE
Hale, LP
Bigner, DD [1 ]
机构
[1] Duke Univ, Med Ctr, Preuss Lab Brain Tumor Res, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Lab Mol Immunopathol, Durham, NC 27710 USA
关键词
TGF beta; TNF-alpha; apoptosis; glioma; cerebral edema;
D O I
10.1016/S0165-5728(98)00017-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously reported that local secretion of either TNF-alpha or TGF beta 1 by intracerebral SMA-560 malignant glioma tumor cells can reduce or eliminate tumor growth in mice. However, the use of TNF-alpha, while improving the overall survival of tumor bearing animals, was associated with early toxic deaths due to cerebral edema. In the present study, we demonstrate that TNF-alpha induces apoptosis of the SMA 560 cell Line, as does TGF beta 1, and that these two cytokines act in an additive fashion to enhance apoptosis and thus, to inhibit SMA 560 cell growth in vitro. Next, we show that the production of TGF beta 1 when added to TNF-alpha production by central nervous system tumors in vivo abrogates any early deaths seen due to TNF-alpha toxicity and leads to a larger percentage of animals surviving CNS tumor challenge. Finally, we demonstrate that the production of TGF beta 1 by tumor cells is associated with the abolition of tumor-associated cerebral edema in both TNF-alpha and in non-TNF-alpha producing tumors. These results are important for the development of effective and less toxic therapies for brain tumors, as well as for examining the pathogenesis of tumor-related cerebral edema. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 31 条
[1]  
Ashley DM, 1998, CANCER RES, V58, P302
[2]   UNRAVELING FUNCTION IN THE TNF LIGAND AND RECEPTOR FAMILIES [J].
BEUTLER, B ;
VANHUFFEL, C .
SCIENCE, 1994, 264 (5159) :667-668
[3]  
Coligan J.E., 1994, Current protocols in immunology
[4]  
CRISCUOLO GR, 1993, YALE J BIOL MED, V66, P277
[5]   THE NEURO-ENDOCRINE EFFECTS OF INTERLEUKIN-2 TREATMENT [J].
DENICOFF, KD ;
DURKIN, TM ;
LOTZE, MT ;
QUINLAN, PE ;
DAVIS, CL ;
LISTWAK, SJ ;
ROSENBERG, SA ;
RUBINOW, DR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (02) :402-410
[6]   THE NEUROPSYCHIATRIC EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
DENICOFF, KD ;
RUBINOW, DR ;
PAPA, MZ ;
SIMPSON, C ;
SEIPP, CA ;
LOTZE, MT ;
CHANG, AE ;
ROSENSTEIN, D ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) :293-300
[7]   TGF-BETA-RECEPTOR-MEDIATED SIGNALING [J].
DERYNCK, R .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (12) :548-553
[8]   VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].
DRANOFF, G ;
JAFFEE, E ;
LAZENBY, A ;
GOLUMBEK, P ;
LEVITSKY, H ;
BROSE, K ;
JACKSON, V ;
HAMADA, H ;
PARDOLL, D ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543
[9]  
FREI K, 1993, INT REV EXP PATHOL, V34, P183
[10]  
Gutin P H, 1977, Natl Cancer Inst Monogr, V46, P151